- Report
- January 2024
- 175 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- January 2024
- 175 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- January 2024
- 200 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- January 2024
- 200 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- January 2024
- 200 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- January 2024
- 200 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- January 2024
- 200 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- December 2023
- 200 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- January 2024
- 150 Pages
Global
From €4658EUR$4,850USD£4,010GBP
- Report
- January 2024
- 150 Pages
Global
From €4658EUR$4,850USD£4,010GBP
- Report
- January 2024
- 150 Pages
Global
From €4658EUR$4,850USD£4,010GBP
- Report
- October 2023
- 150 Pages
Global
From €4658EUR$4,850USD£4,010GBP
- Report
- August 2023
- 115 Pages
Global
From €2161EUR$2,250USD£1,861GBP
- Report
- May 2024
- 181 Pages
Global
From €3241EUR$3,374USD£2,790GBP
€3601EUR$3,749USD£3,100GBP
- Report
- May 2024
- 181 Pages
Global
From €3241EUR$3,374USD£2,790GBP
€3601EUR$3,749USD£3,100GBP
- Report
- April 2024
- 137 Pages
Global
From €3745EUR$3,899USD£3,224GBP
- Report
- November 2023
- 140 Pages
Global
From €2400EUR$2,499USD£2,066GBP
- Report
- November 2023
- 140 Pages
Global
From €2400EUR$2,499USD£2,066GBP
- Report
- June 2023
- 139 Pages
Global
From €2400EUR$2,499USD£2,066GBP
- Report
- May 2024
- 194 Pages
Global
From €4754EUR$4,950USD£4,093GBP
The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics.
The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more